Sobi’s research and product portfolio is primarily focused on haemophilia, inflammation and genetic and metabolic diseases. They have world-class capabilities in protein biochemistry and biologics manufacturing development – validated by leading industry partners. Their organisation spans 24 countries, delivering therapies to patients in 67 countries across the globe.
- Bli medlem
- Om SwedenBIO